Fundraising FoxRebound Therapeutics
AcquiredIrvine, US · Founded 2015 · Delaware corporation · 1 known investors
Find your way into Rebound Therapeutics
Sign up to see every warm intro you have to Rebound Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rebound Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Acquired by Integra LifeSciences Holdings Corporation September 2019 · terms undisclosed · source ↗
Rebound Therapeutics developed single-use minimally invasive surgical devices with integrated cameras, optics, and illumination for neurosurgical visualization and treatment, such as accessing and removing intracranial hematomas.
Founders & leadership
TP
Tracy PearsonExecutive
JJ
Jeffrey J. ValkoExecutive
MR
Michael R. HensonNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$20.3M disclosed across 2 rounds · 2015–2017
▶$16.5MraisedJul 2017 · 49 investors · Other TechnologyRule 506(b)
▶$16.5MraisedJul 2017 · 49 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Tracy PearsonExecutive Officer
- Michael R. HensonExecutive Officer, Director
- Jeffrey J. ValkoExecutive Officer, Director
- Offering amount
- $16.5M
- Amount sold
- $16.5M
- Minimum investment
- $5K
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$3.8MraisedDec 2015 · 29 investors · Other TechnologyRule 506(b)
▶$3.8MraisedDec 2015 · 29 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Tracy PearsonExecutive Officer
- Michael R. HensonExecutive Officer, Director
- Jeffrey J. ValkoExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $3.8M
- Minimum investment
- $10K
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Rebound Therapeutics do?
- Rebound Therapeutics developed single-use minimally invasive surgical devices with integrated cameras, optics, and illumination for neurosurgical visualization and treatment, such as accessing and removing intracranial hematomas.
- Who are Rebound Therapeutics's investors?
- Rebound Therapeutics's investors include 415 Capital.
- How much funding has Rebound Therapeutics raised?
- Rebound Therapeutics has disclosed $20.3M raised across 2 rounds.
- Where is Rebound Therapeutics headquartered?
- Rebound Therapeutics is headquartered in Irvine, US.